An Introduction to Interventional Cardiology
Interventional cardiology involves the use of intravascular, catheter-based techniques to treat patients with cardiovascular disease. The field has seen significant advances over the past decade, such as new imaging technologies and devices.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Interventional Cardiology Content
David Keane, AF Symposium 2021: Challenges in Catheter Ablation
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about the current challenges procedural duration and overall success in catheter ablation, and the most exciting innovations to aim to overcome these. Questions: What are the current challenges in catheter ablation in terms of procedural duration and overall success? (0.13) What are the […]
David Keane, AF Symposium 2021: Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about atrial fibrillation in patients with hypertrophic cardiomyopathy. Questions: What is the incidence of atrial fibrillation (AF) in people with hypertrophic cardiomyopathy (HCM)? (0.13) What is known about the efficacy and safety of catheter ablation of AF in patients with HCM compared to […]
Andrea Natale, AF Symposium 2021: Impact of Catheter Ablation on Quality of Life and Health Care Utilization
We spoke to Dr Andrea Natale (Texas Cardiac Arrhythmia Institute, Austin, TX, USA) about the most exciting recent innovations in catheter ablation technology. Questions: What is the impact of atrial fibrillation (AF) ablation on healthcare utilization and quality of life? (0.13) How should these data influence the timing of ablation strategies? (2.40) Speaker disclosures: Dr […]
Luigi Di Biase, AF Symposium 2021: Innovations in Catheter Ablation Technology
We spoke to Dr Luigi Di Biase (Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA) about the most exciting recent innovations in catheter ablation technology. Questions: Could you give us a brief overview of the most exciting recent innovations in catheter ablation technology? (0.18) What evidence supports the effectiveness of these […]
Luigi Di Biase, AF Symposium 2021: Current and Emerging Strategies for the Treatment of Persistent Atrial Fibrillation
We spoke to Dr Luigi Di Biase (Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA) on the current and new, emerging treatment strategies for the treatment of persistent atrial fibrillation, including the limitations of current pulmonary vein isolation, the concept of “beyond PVI” and clinical evidence supporting new ablation targets. Questions: […]
A Review of Bleeding Risk with Impella-supported High-risk Percutaneous Coronary Intervention
Heart International. 2020;14(2):92-99 DOI: https://doi.org/10.17925/HI.2020.14.2.92
Percutaneous coronary intervention (PCI) has evolved over recent years, with increasingly more complex, high-risk procedures being performed, including in patients with multivessel coronary artery disease with or without left main disease, often complicated by severe left ventricular (LV) dysfunction.1 In addition, decisions about coronary bypass surgery or PCI often focus not only on coronary anatomy, […]
Summary of Practice Considerations for Percutaneous Coronary Intervention of Left Main Bifurcation Disease
Heart International. 2020;14(2):69-72 DOI: https://doi.org/10.17925/HI.2020.14.2.69
Technical approaches to left main (LM) revascularisation by percutaneous techniques continues to be in evolution. This manuscript will attempt to summarise the current best practices for LM percutaneous coronary intervention (PCI). Following a clinical decision for PCI of left main bifurcation (LMB) stenosis, based on angiographic, imaging and functional severity, and supported by current guidelines […]
Drug-coated Balloons or Drug-eluting Stents – Determining an Optimum Strategy for Patients with High Bleeding Risk
Heart International. 2020;14(2):100-4 DOI: https://doi.org/10.17925/HI.2020.14.2.100
Coronary artery disease is the leading cause of morbidity and mortality globally.1 Dual antiplatelet therapy (DAPT), in the form of aspirin and a P2Y12 inhibitor, is the mainstay of pharmacotherapeutic treatment for acute coronary syndrome and prevention of stent thrombosis after percutaneous coronary intervention (PCI) for acute coronary syndrome or stable coronary disease. DAPT with ticlopidine plus […]
The MyVal Transcatheter Heart Valve System for the Treatment of Severe Aortic Stenosis – Current Evidence and Future Directions
Heart International. 2020;14(2):86-91 DOI: https://doi.org/10.17925/HI.2020.14.2.86
Aortic stenosis is a common degenerative valve disease and its prevalence increases with age.1 If untreated, severe symptomatic aortic stenosis leads to significant morbidity and mortality.2 Although surgical aortic valve replacement (SAVR) is a well-established treatment option for this condition, more than 30% of patients are not suitable candidates for SAVR due to increased operative risks; advanced […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!